Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)
Autor: | Vukusic, Sandra, Brassat, David, de Seze, Jerome, Izquierdo, Guillermo, Lysandropoulos, Andreas, Moll, Wibe, Vanopdenbosch, Ludo, Arque, Maria Jesus, Kertous, Mehdi, Rufi, Pascal, Oreja-Guevara, Celia |
---|---|
Zdroj: | In Multiple Sclerosis and Related Disorders April 2019 29:7-14 |
Databáze: | ScienceDirect |
Externí odkaz: |